1 report

Core earnings per share growth ahead of sales## Core## operating profit increased ##% in the first half, excluding a one-time income from the sale of filgrastim rights in 2014.

  • Clinical Trial
  • CT Scan
  • Healthcare
  • Polyclonal Antibody
  • GlobalData's company